February 26, 2026 · Form 4 insider transaction
Stapley Marc bought 139,074 shares of Veracyte, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 70,239 PSUs vested on February 26, 2026, and the remaining 68,835 PSUs will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date.; Includes 696 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.